Loan Loss Reserves / Non-Performing Loans (Quarterly)

Loan Loss Reserves / Non-Performing Loans: Allowance for bad loans as a portion of total loans made. Calculated as: Loan Loss Reserves / Non-Performing Loans

Aoxing Pharmaceutical Company, Inc. (AOXG) Loan Loss Reserves / Non-Performing Loans data is not available.

Quarterly Annual

Figures for fiscal quarter ending 2017-03-31

Income Statement Financials
Revenue	$5.70M
Net Income	$0.13M
Cost of Goods Sold	$1.28M
Gross Profit	$4.42M
Operating Expenses	$4.82M
Operating Income	$0.88M
Non-Operating Income/Expense	$-0.58M
Pre-Tax Income	$0.30M
Normalized Pre-Tax Income	$0.30M
Income after Taxes	$0.14M
Income from Continuous Operations	$0.14M
Consolidated Net Income/Loss	$0.14M
Normalized Income after Taxes	$0.14M
EBIT	$0.88M
EBITDA	$1.12M
Weighted-Average Shares Outstanding (Basic)	76.21M
Weighted-Average Shares Outstanding (Diluted)	76.21M
Earnings per Share (EPS) (Basic)	$0.00
Earnings per Share (EPS) (Diluted)	$0.00
Balance Sheet Financials
Current Assets	$34.80M
Property, Plant, and Equipment	$24.04M
Long-Term Assets	$27.66M
Total Assets	$62.47M
Current Liabilities	$43.97M
Long-Term Debt	$0.10M
Long-Term Liabilities	$0.41M
Total Liabilities	$44.38M
Common Equity	$18.09M
Tangible Shareholders Equity	$16.29M
Shareholders Equity	$18.09M
Common Shares Outstanding	76.21M
Cash Flow Statement Financials
Cash Flow from Operating Activities	$-2.79M
Cash Flow from Investing Activities	$-0.01M
Cash Flow from Financial Activities	$3.18M
Beginning Cash	$6.91M
End Cash	$7.08M
Increase/Decrease in Cash	$0.17M
Stock-Based Compensation	$0.02M
Common Stock Dividends Paid	--
Preferred Stock Dividends Paid	--
Fundamental Metrics & Ratios
Current Ratio	0.79
Non-Performing Assets / Total Loans	--
Loan Loss Reserves / Non-Performing Loans	--
Debt to Capital Ratio	0.01
Debt to Equity Ratio	1.53
Gross Margin	77.53%
Operating Margin	15.41%
EBIT Margin	15.41%
EBITDA Margin	--
Pre-Tax Profit Margin	5.21%
Profit Margin	2.32%
Free Cash Flow	$-2.80M
Loss Ratio	--
Expense Ratio	--
Combined Ratio	--
Asset Turnover	0.09
Inventory Turnover	0.53
Receiveable Turnover	0.39
Days Sales in Receivables	228.95
Return on Equity	0.79%
Return on Tangible Equity	0.88%
Return on Assets	0.23%
Return on Investments	0.79%
Book Value Per Share	$0.24
Free Cash Flow per Share	$-0.04
Operating Cash Flow per Share	$-0.04

Data from Zacks Investment Research, Inc.